Related Experiment Videos
Cancer fatigue: the way forward
Gregory Curt1, Patrick G Johnston
1National Cancer Institute, Bethesda, Maryland, USA. Gcurt@TheOncologist.com
The Oncologist
|March 11, 2003
Summary
Cancer-related fatigue is a widespread and undertreated problem affecting most patients. Research and public awareness are crucial for developing effective diagnosis and treatment guidelines for this debilitating symptom.
Area of Science:
- Oncology
- Symptom Management
- Patient Advocacy
Background:
- Cancer-related fatigue is significantly under-researched compared to pain and depression, despite its high prevalence.
- A recent State-of-the-Science Conference highlighted the underdeveloped nature of research in cancer fatigue.
- Patient surveys indicate substantial fatigue prevalence, with 53% experiencing it daily and 80% monthly.
Purpose of the Study:
- To highlight the under-researched nature of cancer-related fatigue.
- To compare patient experiences of fatigue in Ireland and the U.S.
- To advocate for increased research and awareness to improve diagnosis and treatment.
Main Methods:
- Analysis of patient survey data on fatigue from Ireland (All Ireland Fatigue Coalition) and the U.S.
- Comparison of fatigue prevalence, duration, patient-reported discussions, and economic impacts between the two regions.
Main Results:
- High prevalence of daily (53%) and monthly (80%) fatigue reported in both Ireland and the U.S.
- Significant differences observed in fatigue bout duration, symptom discussion, and economic impact between Irish and U.S. patients.
- Cancer-related fatigue is consistently underreported and undertreated across both regions.
Conclusions:
- Cancer-related fatigue is a major, yet understudied, issue affecting the majority of cancer patients.
- Increased research, public awareness, and guideline development are urgently needed.
- Initiatives like the All Ireland Fatigue Coalition are vital for addressing this under-recognized symptom.